Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

Press releases published on March 9, 2026

Mar. 9, 2026

Women Farmers Urge Gender Equality Focus to Boost Food Security

Indeterminate EIN Presswire

Mar. 9, 2026

ARTHI RABIKRISSON SELECTED AS TOP INTERNATIONAL LEADERSHIP COACH OF THE DECADE BY IAOTP

Indeterminate EIN Presswire

Mar. 9, 2026

Austral Construction livre deux hôpitaux au Congo-Brazzaville

Indeterminate EIN Presswire

Mar. 9, 2026

Austral Construction delivers two hospitals in Congo-Brazzaville

Indeterminate EIN Presswire

Mar. 9, 2026

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

Indeterminate GlobeNewswire

Mar. 9, 2026

MASAI UJIRI AND GIANTS OF AFRICA EXPAND BUILT WITHIN COMMUNITY BASKETBALL COURT INITIATIVE INTO THE SAHEL REGION

Indeterminate EIN Presswire

Mar. 9, 2026

MegaWatt Announces Proposed Consolidation of Shares

Indeterminate GlobeNewswire

Mar. 9, 2026

Novonesis named a Great Employer to Work For in North Carolina

Indeterminate GlobeNewswire

Mar. 9, 2026

Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026

Indeterminate GlobeNewswire

Mar. 9, 2026

Rapport Therapeutics与Tenacia Biotechnology宣布达成大中华区RAP-219开发与商业化战略合作

Indeterminate GlobeNewswire

Mar. 9, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

Indeterminate GlobeNewswire

Mar. 9, 2026

AEON Biopharma Appoints John Bencich as Chief Financial Officer

Indeterminate GlobeNewswire

Mar. 9, 2026

Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 9, 2026

Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C

Indeterminate GlobeNewswire

Mar. 9, 2026

Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026

Indeterminate GlobeNewswire

Mar. 9, 2026

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Indeterminate GlobeNewswire

Mar. 9, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 9, 2026

Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris 

Indeterminate GlobeNewswire

Mar. 9, 2026

Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study

Indeterminate GlobeNewswire

Mar. 9, 2026

Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients

Indeterminate GlobeNewswire